| Dr Phillip E Tobash, DO | |
|
680 E Main St, Schuylkill Haven, PA 17972-1428 | |
| (570) 385-4455 | |
| (570) 385-7273 |
| Full Name | Dr Phillip E Tobash |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 680 E Main St, Schuylkill Haven, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659344455 | NPI | - | NPPES |
| 001100038 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS005898L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisiner Home Health | Hazleton, PA | Home health agency |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| Geisinger St. Luke's Hospital | Orwigsburg, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Medical Group P C | 1355247180 | 101 |
| Img Nursing Home Care, P.c. | 8628491735 | 11 |
News Archive
Heavy smokers may experience sadness after quitting because early withdrawal leads to an increase in the mood-related brain protein monoamine oxidase A (MAO-A), a new study by the Centre for Addiction and Mental Health (CAMH) has shown. This finding, which was published in the Archives of General Psychiatry, may also explain why heavy smokers are at high risk for clinical depression.
According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.
As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International - a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential.
The federal health law requires the plans to pay out at least 85 percent of their premium dollars on medical expenses, or refund the excess revenue to the government.
Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease, today announced positive data from its Phase 1 trial of AKB-9778 for the treatment of diabetic macular edema.
› Verified 6 days ago
| Entity Name | Integrated Medical Group P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336102268 PECOS PAC ID: 1355247180 Enrollment ID: O20031211000232 |
News Archive
Heavy smokers may experience sadness after quitting because early withdrawal leads to an increase in the mood-related brain protein monoamine oxidase A (MAO-A), a new study by the Centre for Addiction and Mental Health (CAMH) has shown. This finding, which was published in the Archives of General Psychiatry, may also explain why heavy smokers are at high risk for clinical depression.
According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.
As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International - a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential.
The federal health law requires the plans to pay out at least 85 percent of their premium dollars on medical expenses, or refund the excess revenue to the government.
Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease, today announced positive data from its Phase 1 trial of AKB-9778 for the treatment of diabetic macular edema.
› Verified 6 days ago
| Entity Name | Img Nursing Home Care, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144843897 PECOS PAC ID: 8628491735 Enrollment ID: O20200708002046 |
News Archive
Heavy smokers may experience sadness after quitting because early withdrawal leads to an increase in the mood-related brain protein monoamine oxidase A (MAO-A), a new study by the Centre for Addiction and Mental Health (CAMH) has shown. This finding, which was published in the Archives of General Psychiatry, may also explain why heavy smokers are at high risk for clinical depression.
According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.
As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International - a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential.
The federal health law requires the plans to pay out at least 85 percent of their premium dollars on medical expenses, or refund the excess revenue to the government.
Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease, today announced positive data from its Phase 1 trial of AKB-9778 for the treatment of diabetic macular edema.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Phillip E Tobash, DO 680 E Main St, Schuylkill Haven, PA 17972-1428 Ph: (570) 385-4455 | Dr Phillip E Tobash, DO 680 E Main St, Schuylkill Haven, PA 17972-1428 Ph: (570) 385-4455 |
News Archive
Heavy smokers may experience sadness after quitting because early withdrawal leads to an increase in the mood-related brain protein monoamine oxidase A (MAO-A), a new study by the Centre for Addiction and Mental Health (CAMH) has shown. This finding, which was published in the Archives of General Psychiatry, may also explain why heavy smokers are at high risk for clinical depression.
According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.
As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International - a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential.
The federal health law requires the plans to pay out at least 85 percent of their premium dollars on medical expenses, or refund the excess revenue to the government.
Aerpio Therapeutics, a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease, today announced positive data from its Phase 1 trial of AKB-9778 for the treatment of diabetic macular edema.
› Verified 6 days ago
Margaret Joan Young, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 523 S Garfield Ave, Schuylkill Haven, PA 17972 Phone: 570-385-3826 Fax: 570-385-4125 | |
Dr. Michael J Zawisza, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 523 S Garfield Ave, Schuylkill Haven, PA 17972 Phone: 570-385-3826 Fax: 570-385-4125 | |
Herbert Charles Rubright Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 University Drive, Schuylkill Haven, PA 17972 Phone: 570-385-0331 Fax: 570-385-1007 |